
U.S. federal authorities have charged John Thomas Howard, treasurer and director of CANARX, a Canadian prescription drug company, with smuggling and conspiracy related to the illegal importation of medications into the United States. Howard was arrested Sunday, with charges also including introducing misbranded drugs into interstate commerce and illegal drug importation. His brother, Bob Howard, who serves as president and director of CANARX, is also named in the investigation but has not yet been apprehended.
According to court documents and an FDA affidavit, the alleged scheme operated over an extended period, covering activities from early 2017 through mid-2026. CANARX, founded in 2002 and based in Windsor, Ontario, describes itself on its website as an international prescription provider for American patients, claiming to source medications from Canada, the United Kingdom, Australia, and New Zealand. The company’s general counsel stated that the leadership denies all charges and expects vindication through the legal process.
CANARX operates within a broader industry category known as alternative funding programs, or AFPs, which have grown in prominence as prescription drug costs have risen across the United States. These entities offer specialty medications at reduced prices to employers and their workers by obtaining drugs from overseas suppliers and shipping them directly to patients. A CNBC investigation documented how some AFPs have become integrated into the U.S. healthcare system, with certain employers mandating their use.
The FDA has maintained that importing prescription drugs from abroad to substitute for FDA-approved medications is illegal in most circumstances and presents safety concerns. The agency previously issued a warning letter to CANARX in 2019 and seized medications from the company in 2023 that it deemed potentially misbranded and counterfeit. Additionally, pharmaceutical manufacturer Gilead Sciences has filed a separate civil lawsuit against CANARX and other companies, alleging illegal importation of its HIV treatment medication Biktarvy.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI